CVX CHEVRON CORP Insider Trading

Director John B Hess sold 380,000 shares ($73.4M) at $191.52–$197.45 on 2026-05-20; reduces holdings by 57.7%.

John B Hess, a Director at Chevron, executed 7 separate sales totaling 380,000 shares for $73,414,765.34 across a narrow price range ($191.52–$197.45) on a single day, reducing his holdings by 57.7% from 658,045 to 278,045 shares. This is a material reduction in his disclosed position. His prior sales at Chevron show a timing pattern of 0 out of 5 being well-timed at the 90-day mark—all five prior CVX sales were followed by positive returns, meaning the insider sold before subsequent gains. The current stock price of $191.43 is 10.8% below the 52-week high of $214.71, and the company reports a P/E of 34.62 with annual revenue declining 6.8% year-over-year, even as the stock has risen 4.1% over the past 90 days. The pattern of large-block sales concentrated on one date at progressively higher prices, combined with historically poor timing on prior CVX sales and a deteriorating revenue trend, warrants attention to whether this transaction reflects any shift in Hess's portfolio positioning.

Director John B Hess sells 195,000 CVX shares worth $36M; stock near 13-month lows after recent decline.

Director John B Hess executed a substantial three-part sale totaling approximately 195,000 shares, reducing his holdings by significant percentages in each tranche. This is the second time in roughly six months that Hess has sold CVX shares—his prior sales in late November resulted in the stock rising afterward over the following three months, making those exits poorly timed. The stock is currently trading well below its highs and has experienced a sharp pullback in recent weeks, creating a backdrop where this director is choosing to sell rather than hold through the weakness. Hess's longer-term track record across all holdings shows more discipline on purchases (with gains following those buys) than on sales, yet his previous CVX sales specifically worked out poorly as the stock climbed afterward, raising questions about his timing in this company in particular. Against a backdrop of modest fundamentals—the company is profitable but facing revenue headwinds—a director stepping up sales volume warrants attention, even though the poor historical timing of his CVX exits suggests his sales may not be predictive of further declines.